H. ROSSITER HORN, RPH
H. Rossiter Horn has over 25 years of experience in the biotech and pharmaceutical industries, working with both Fortune 50 and start-up companies. He directed a successful strategic clinical development program at SangStat Medical Corporation, was responsible for a multi-million-dollar sales territory with Ortho Biotech, and enjoyed a successful sales career at Knoll Pharmaceuticals. Mr. Horn holds a B.S. (R.Ph.) degree in Pharmacy from the Temple University School of Pharmacy and a B.S. in Biology from the University of Scranton.
JOE FIRCA, PH.D.
Chief Scientific Officer
Dr. Firca has more than 35 years of extensive operating and product development knowledge and is a recognized leader in the life science and biotechnology arena in matters of research, technology assessment, and regulatory issues. He has a combined 18 years leading research groups at Baxter International and Abbott Laboratories. Throughout his distinguished career, Dr. Firca has contributed to numerous publications and patents. Some of his contributions include co-development of the first automated DNA synthesizer; Abbott liaison to Amgen, Inc. for a joint collaboration on DNA probes for infectious diseases; systems integration for major instrumentation in blood donor screening; and the development of numerous approved immunoassays for the detection of infectious disease agents. Most recently he served as Adjunct Associate Professor in Biomedical Engineering and Associate Director of Corporate Relations at the McCormick School of Engineering, Northwestern University. Dr. Firca holds a Ph.D. in Microbiology (Microbial Genetics) from the University of Cincinnati, an M.S. in Microbiology (Mycology) from Duquesne University and a B.S. in Biology from Xavier University and has done postdoctoral work at Argonne National Laboratory.
ED CORRIGAN, PH.D.
Chief Financial Officer
Dr. Corrigan has had extensive financial management, regulatory compliance, and retail and investment banking experience in both the private and public sectors. He is the founder of a successful early stage biotechnology company that has been in business 15 years. He has overseen a biotechnology laboratory and supervised the development of a hand-held biosensor instrument now on the market. His training is in public finance and economics. Mr. Corrigan holds a B.A degree from Rutgers College, and M.A. (Economics) and Ph.D. (International Economics) degrees from the University of Denver.
Investment and Compliance Officer
Mr Adashek has over 40 years of successful complex problem solving, project development, and business ownership. Mr. Adashek has been involved in multiple startups converting creative business ideas to profitable companies. He has extensive experiences in funding medical and biomedical, sports/recreational, manufacturing, real estate financing, as well as leasing and financial service. He has structured financing for emerging companies and extensive experience in advising banks and other financial institutions. Mr. Adashek is a non-practicing CPA.
Chief Executive Officer
Mr. Bernstein has over 35 years of executive management experience in sales, marketing, and related services. His corporate experience includes medical device, healthcare, telemedicine, medical services, and molecular modeling. He was co- Founder of Specialists On-Call, a 24/7 emergency telemedicine company. He has developed distribution channels domestically and internationally, managed more than 12 sales teams, comprising in some cases more than 100 sales people with an annual quota of $500M. His experience with companies including Fortune 100 Companies and extensive start-up experience.